LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 2019
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

Steatosis in chronic hepatitis B: Prevalence and correlation with biochemical, histologic, viral, and metabolic parameters

Rastogi Archana, Sakhuja Puja, Kumar Ashish, Hissar Syed, Jain Akshat, Gondal Ranjana, Sarin Shiv Kumar

Year : 2011| Volume: 54| Issue : 3 | Page no: 454-459

   This article has been cited by
 
1 Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
Noam Peleg,Assaf Issachar,Orly Sneh Arbib,Michal Cohen-Naftaly,Marius Braun,Moshe Leshno,Alon Barsheshet,Amir Shlomai
JHEP Reports. 2019; 1(1): 9
[Pubmed]  [Google Scholar] [DOI]
2 Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study
R. W. H. Hui,W.-K. Seto,K.-S. Cheung,L.-Y. Mak,K. S. H. Liu,J. Fung,D. K.-H. Wong,C.-L. Lai,M.-F. Yuen
Journal of Viral Hepatitis. 2018; 25(1): 97
[Pubmed]  [Google Scholar] [DOI]
3 INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Anil Arora,Shivaram P. Singh,Ashish Kumar,Vivek A. Saraswat,Rakesh Aggarwal,Manisha Bangar,Pradip Bhaumik,Harshad Devarbhavi,Radha K. Dhiman,Vinod K. Dixit,Ashish Goel,Bhabadev Goswami,Dharmesh Kapoor,Kaushal Madan,Jimmy Narayan,Sandeep Nijhawan,Gaurav Pandey,Ramesh R. Rai,Manoj K. Sahu,Neeraj Saraf,Neeraj Shalimar,Thrivikrama Shenoy,Varghese Thomas,Manav Wadhawan
Journal of Clinical and Experimental Hepatology. 2018; 8(1): 58
[Pubmed]  [Google Scholar] [DOI]
4 Fatty liver checkmates hepatitis B virus
Gayatri Ramakrishna,Nirupma Trehanpati
Hepatology International. 2018; 12(5): 387
[Pubmed]  [Google Scholar] [DOI]
5 Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy
Ira M. Jacobson,Mary K. Washington,Maria Buti,Alexander Thompson,Nezam Afdhal,Robert Flisiak,Ulus Salih Akarca,Konstantin G. Tchernev,John F. Flaherty,Raul Aguilar Schall,Robert P. Myers,G. Mani Subramanian,John G. McHutchison,Zobair Younossi,Patrick Marcellin,Keyur Patel
Clinical Gastroenterology and Hepatology. 2017; 15(7): 1087
[Pubmed]  [Google Scholar] [DOI]
6 Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection
Anthony W.H. Chan,Grace L.H. Wong,Vincent W.S. Wong
Current Hepatology Reports. 2017; 16(2): 97
[Pubmed]  [Google Scholar] [DOI]
7 New trends on obesity and NAFLD in Asia
Jian-Gao Fan,Seung-Up Kim,Vincent Wai-Sun Wong
Journal of Hepatology. 2017; 67(4): 862
[Pubmed]  [Google Scholar] [DOI]
8 A “systems medicine” approach to the study of non-alcoholic fatty liver disease
Salvatore Petta,Luca Valenti,Elisabetta Bugianesi,Giovanni Targher,Stefano Bellentani,Ferruccio Bonino,Ele Ferrannini,Carmela Loguercio,Amedeo Lonardo,Fabio Marra,Marcello Mancini,Luca Miele,Valerio Nobili,Gianluca Svegliati Baroni,Federico Alessandro,Stefano Ballestri,Maurizia Rossana Brunetto,Barbara Coco,Antonio Grieco,Silvia Fargion,Loreta Kondili,Fabio Nascimbeni,Anna Prinster,Dante Romagnoli,Stefano Taddei,Ester Vanni,Stefano Vella
Digestive and Liver Disease. 2016; 48(3): 333
[Pubmed]  [Google Scholar] [DOI]
9 Association between hepatitis B and metabolic syndrome: Current state of the art
Peter Jarcuska
World Journal of Gastroenterology. 2016; 22(1): 155
[Pubmed]  [Google Scholar] [DOI]
10 Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Heather L. Stevenson,Netanya S. Utay
Tropical Diseases, Travel Medicine and Vaccines. 2016; 2(1)
[Pubmed]  [Google Scholar] [DOI]
11 Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response
Rui-Nan Zhang,Qin Pan,Zheng Zhang,Hai-Xia Cao,Feng Shen,Jian-Gao Fan
Hepatitis Monthly. 2015; 15(5)
[Pubmed]  [Google Scholar] [DOI]
12 Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact
Chu-wen Lin,Xiao-li Huang,Hai-lin Liu,Yan Wang
Digestive Diseases and Sciences. 2015; 60(12): 3513
[Pubmed]  [Google Scholar] [DOI]
13 A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study
Fen Liu,Feng Zou,Xiwei Wang,Huaidong Hu,Peng Hu,Hong Ren
Virology Journal. 2015; 12(1)
[Pubmed]  [Google Scholar] [DOI]
14 Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects
Wen-Jin Ding,Man-Man Wang,Gong-Sui Wang,Fen Shen,Jian-Jun Qin,Jian-Gao Fan
Journal of Gastroenterology and Hepatology. 2015; 30(12): 1753
[Pubmed]  [Google Scholar] [DOI]
15 Non-invasive assessment of fatty liver
Anna Egresi,Gabriella Lengyel,Krisztina Hagymási
Orvosi Hetilap. 2015; 156(14): 543
[Pubmed]  [Google Scholar] [DOI]
16 Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
Chia-Chi Wang,Tai-Chung Tseng,Jia-Horng Kao
Journal of Gastroenterology and Hepatology. 2015; 30(1): 14
[Pubmed]  [Google Scholar] [DOI]
17 Hepatic Steatosis as a Predictive Factor of Antiviral Effect of Pegylated Interferon Therapy in Patients With Hepatitis B
L. Gong,J. Liu,J. Wang,G.Q. Lou,J.P. Shi
Transplantation Proceedings. 2015; 47(10): 2886
[Pubmed]  [Google Scholar] [DOI]
18 Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
P. Loria,G. Marchesini,F. Nascimbeni,S. Ballestri,M. Maurantonio,F. Carubbi,V. Ratziu,A. Lonardo
Atherosclerosis. 2014; 232(1): 99
[Pubmed]  [Google Scholar] [DOI]
19 Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors
Man-Man Wang,Gong-Sui Wang,Feng Shen,Guang-Yu Chen,Qin Pan,Jian-Gao Fan
Digestive Diseases and Sciences. 2014;
[Pubmed]  [Google Scholar] [DOI]
20 Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
Rosa Zampino
World Journal of Hepatology. 2014; 6(9): 677
[Pubmed]  [Google Scholar] [DOI]
21 Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers
Angélica Luciana Nau,Júlia Cristina Soares,Maria Beatriz Cacese Shiozawa,Esther Buzaglo Dantas-Corrêa,Leonardo de Lucca Schiavon,Janaína Luz Narciso-Schiavon
Revista da Sociedade Brasileira de Medicina Tropical. 2014; 47(2): 158
[Pubmed]  [Google Scholar] [DOI]
22 Hepatic Steatosis: Prevalence and Host/Viral Risk Factors in Iranian Patients with Chronic Hepatitis B Infection
Vahdat Poortahmasebi,Seyed Moayed Alavian,Hossein Keyvani,Mehdi Norouzi,Mahmood Mahmoodi,Seyed Mohammad Jazayeri
Asian Pacific Journal of Cancer Prevention. 2014; 15(9): 3879
[Pubmed]  [Google Scholar] [DOI]
23 Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?
Manoj Kumar,Archana Rastogi,Tarandeep Singh,Chhagan Behari,Ekta Gupta,Hitendra Garg,Ramesh Kumar,Vikram Bhatia,Shiv K Sarin
Journal of Gastroenterology and Hepatology. 2013; 28(7): 1194
[Pubmed]  [Google Scholar] [DOI]
24 Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model
Zheng Zhang,Qin Pan,Xiao-Yan Duan,Qiang Liu,Guo-Yu Mo,Gui-Rong Rao,Jian-Gao Fan
Journal of Gastroenterology and Hepatology. 2012; 27(12): 1858
[Pubmed]  [Google Scholar] [DOI]
25 Nonalcoholic Fatty Liver Disease in Chronic Hepatitis B and C Patients from Western Amazon
A. C. M. Nascimento,D. R. Maia,S. M. Neto,E. M. Lima,M. Twycross,R. F. Baquette,C. M. O. Lobato
International Journal of Hepatology. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article